‘Best available test’: Advanced PET boosts disease-free survival in patients with prostate cancer October 27, 2020 Incorporating advanced PET into treatment planning for patients with recurrent prostate cancer increases disease-free survival rates and should be adopted into standard practice, according to new research presented Monday.Among those whose cancer returned after prostate removal surgery, 75% who underwent molecular imaging during treatment were cancer-free after three years. That’s compared to 63% of patients who only received traditional imaging to steer their radiation therapy.Read the full article here. About Prostate Cancer Imaging Prostate Cancer News Research Treatment Options More for you
Incorporating advanced PET into treatment planning for patients with recurrent prostate cancer increases disease-free survival rates and should be adopted into standard practice, according to new research presented Monday.Among those whose cancer returned after prostate removal surgery, 75% who underwent molecular imaging during treatment were cancer-free after three years. That’s compared to 63% of patients who only received traditional imaging to steer their radiation therapy.Read the full article here.
Complete the Survey
